SCHEMBL24814458

SCHEMBL24814458

O=C(CS(=O)(=O)c1ccccc1Cl)N1Cc2ccccc2C1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 1/20 0.46
▸ TAS1R1 Q7RTX1 1/20 0.46
▸ TAS1R2 Q8TE23 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.45
▸ NOTUM Q6P988 1/20 0.45
▸ LMNA P02545 3/20 0.43
▸ HPGD P15428 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ GAA P10253 3/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ EGLN1 Q9GZT9 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29986800 1.00 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2ALDH1A1NOTUM
SCHEMBL24814431 0.90 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2ALDH1A1LMNA
SCHEMBL29986760 0.90 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2ALDH1A1LMNA
SCHEMBL29987207 0.86 ALDH1A1 (0.48) TAS1R3TAS1R1TAS1R2ALDH1A1NOTUM
SCHEMBL24815801 0.86 ALDH1A1 (0.48) TAS1R3TAS1R1TAS1R2ALDH1A1NOTUM
SCHEMBL24814425 0.82 GAA (0.47) TAS1R3TAS1R1TAS1R2ALDH1A1NOTUM
SCHEMBL29986907 0.82 GAA (0.47) TAS1R3TAS1R1TAS1R2ALDH1A1NOTUM
SCHEMBL24815673 0.78 SMN1; SMN2 (0.67) ALDH1A1NOTUMLMNAHPGDHTT
SCHEMBL29986910 0.78 SMN1; SMN2 (0.67) ALDH1A1NOTUMLMNAHPGDHTT
SCHEMBL24815704 0.76 L3MBTL1 (0.50) ALDH1A1NOTUMLMNAL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH TAS1R3 4201/4885TAS1R1 4472/4885TAS1R2 3699/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH TAS1R3 4201/4885TAS1R1 4472/4885TAS1R2 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback